Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial... see more

TSX:WLLW - Post Discussion

View:
Post by 123600 on Feb 04, 2022 9:56am

webcast

lots of tech stuf and opportunities. nothing on revenue stream
Comment by jermiah777 on Feb 05, 2022 1:06am
I find that discouraging since the impression left over a year ago was that Willow is transitioning to a revenue generating company. Here we are and nothing stated about revenue? How much longer can the cash hold out? Will we need to raise more money?
Comment by lscfa on Feb 05, 2022 1:15am
The whole damn industry is avoiding giving any guidance. No visibility in an industry shake out.    
Comment by Bullknit101 on Feb 05, 2022 6:38am
InMed Pharma will be reporting some revenues for the first time on 10 Feb and hopefully will give guidance going forward. So far they are supplying CBC and CBT with THCV and CBDV on the way. It's unclear what demand in the market is like. If CBC is that good for depression, I think it would take off. Apparently the market wants all the THCV that can be made. Dissapointed that Willow doesn' ...more  
Comment by lscfa on Feb 12, 2022 10:17pm
Valens finally right-sizing the co. with layoffs and cost-cutting. Co. forecasts ebitda positive by end of 2022. Not impressed. Mgmt should have their salaries cut. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities